{"transactions":[{"id":728483,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-23T22:28:40.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of Envoy Medical, Inc. Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All restricted stock units subject to the RSU Award Grant Notice dated June 19, 2026, will vest as of the date of the official notification by the U.S. Food and Drug Administration (FDA) that it has granted approval (including approval with conditions) for its Acclaim cochlear implant, provided that such announcement occurs during the performance period beginning June 19, 2026 and ending on June 18, 2030."}],"balance_after":1000000,"derivative":{"expiration_date":"2030-06-18","underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000100/form4.xml","form_type":"4"}},{"id":728482,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-23T22:28:40.000Z","date":"2026-06-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 250,000 shares vest on 6/19/27, and 750,000 shares vest pro rata on the 19th of each month thereafter for 36 consecutive months."}],"balance_after":1000000,"derivative":{"exercise_price":0.634,"expiration_date":"2036-06-19","underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000914190-26-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000100/form4.xml","form_type":"4"}},{"id":749053,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-04T20:28:22.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":32856,"price":0.599,"value":19680.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":329946,"source":{"system":"sec-edgar","filing":"0000914190-26-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000095/form4.xml","form_type":"4"}},{"id":900260,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series A-2 Warrants expire on the earlier of (i) five years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has received FDA approval for its Acclaim CI Device."}],"balance_after":62500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":900259,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable upon shareholder approval of the issuance of shares of Class A Common Stock underlying the warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-1 Warrants expire on the earlier of (i) two years from the initial exercise date and (ii) 30 days after the date on which the Company announces that it has submitted a Premarket Approval Application to the Food and Drug Administration (FDA) for its Acclaim CI Device."}],"balance_after":37500,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":900258,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-17T21:45:03.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"balance_after":297090,"source":{"system":"sec-edgar","filing":"0000914190-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000024/form4.xml","form_type":"4"}},{"id":913908,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T22:45:09.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 50,000 shares vest on 2/5/2027, and 150,000 shares vest pro rata on the 5th of each month thereafter for 36 consecutive months."}],"balance_after":200000,"derivative":{"exercise_price":0.53,"expiration_date":"2036-02-05","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000914190-26-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419026000014/form4.xml","form_type":"4"}},{"id":973839,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-10T22:49:36.000Z","date":"2025-11-28","kind":"grant","planned":false,"acquired":true,"shares":18105,"price":0.713,"value":12908.865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":234590,"source":{"system":"sec-edgar","filing":"0000914190-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000091419025000054/form4.xml","form_type":"4"}},{"id":1117208,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-10T00:58:13.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7742,"price":1.2927,"value":10008.0834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":216485,"source":{"system":"sec-edgar","filing":"0001062993-25-011296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011296/form4.xml","form_type":"4"}},{"id":1117207,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-10T00:58:13.000Z","date":"2024-11-30","kind":"grant","planned":false,"acquired":true,"shares":5165,"price":1.94,"value":10020.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":208743,"source":{"system":"sec-edgar","filing":"0001062993-25-011296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299325011296/form4.xml","form_type":"4"}},{"id":1331837,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-12-13T21:10:57.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":16694,"price":0.06,"value":1001.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":110987,"derivative":{"exercise_price":11.5,"expiration_date":"2028-09-29","underlying":"Class A Common Stock","underlying_shares":16694},"source":{"system":"sec-edgar","filing":"0001062993-24-020597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324020597/form4.xml","form_type":"4"}},{"id":1331836,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2024-12-13T21:10:57.000Z","date":"2024-12-11","kind":"purchase","planned":false,"acquired":true,"shares":94293,"price":0.055,"value":5186.115,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":94293,"derivative":{"exercise_price":11.5,"expiration_date":"2028-09-29","underlying":"Class A Common Stock","underlying_shares":94293},"source":{"system":"sec-edgar","filing":"0001062993-24-020597","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324020597/form4.xml","form_type":"4"}},{"id":1468543,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-26T20:06:40.000Z","date":"2024-06-24","kind":"other","planned":false,"acquired":true,"shares":10176,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Family Education Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Cornerstone Growth Group, LP and Cornerstone Growth Group II, LP, of which the reporting person was a non-managing member and did not have voting, dispositive or other rights."}],"balance_after":12720,"source":{"system":"sec-edgar","filing":"0001062993-24-013065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324013065/form4.xml","form_type":"4"}},{"id":1468542,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2024-06-26T20:06:40.000Z","date":"2024-06-24","kind":"other","planned":false,"acquired":true,"shares":74784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro rata distribution from Cornerstone Growth Group, LP and Cornerstone Growth Group II, LP, of which the reporting person was a non-managing member and did not have voting, dispositive or other rights."}],"balance_after":195615,"source":{"system":"sec-edgar","filing":"0001062993-24-013065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299324013065/form4.xml","form_type":"4"}},{"id":1730097,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-24T21:09:42.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":2380,"price":0.92,"value":2189.6,"ownership":{"direct":true},"balance_after":120831,"source":{"system":"sec-edgar","filing":"0001062993-23-021438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323021438/form4.xml","form_type":"4"}},{"id":1730096,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-24T21:09:42.000Z","date":"2023-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.98,"value":9800.0,"ownership":{"direct":true},"balance_after":118451,"source":{"system":"sec-edgar","filing":"0001062993-23-021438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323021438/form4.xml","form_type":"4"}},{"id":1758732,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":35866,"kind":"person","name":"Lucas Brent T.","position":1,"cik":"0001994382","reported_name":"Lucas Brent T.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-17T21:25:45.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":879749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 659,811 shares vest on 10/15/2023, and 219,938 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months."}],"balance_after":879749,"derivative":{"exercise_price":2.4,"expiration_date":"2033-10-15","underlying":"Class A Common Stock","underlying_shares":879749},"source":{"system":"sec-edgar","filing":"0001062993-23-019479","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1840877/000106299323019479/form4.xml","form_type":"4"}}]}